E714-0330 Screening compound: 3-{2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3H,4H,6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-one

E714-0330 Screening compound: 3-{2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3H,4H,6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-one
E714-0330 Screening compound: 3-{2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3H,4H,6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound E714-0330
3-{2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3H,4H,6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E714-0330

Molecular Formula

C22H25ClN6O2 (C22 H25 ClN6 O2)

Compound Name

3-{2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3H,4H,6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-one

IUPAC name

3-{2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3H4H6H7H8H9H10H-azepino[21-h]purin-4-one

SMILES

O=C(CN(C=Nc1c2nc3n1CCCCC3)C2=O)N(CC1)CCN1c(cc1)ccc1Cl

InChI

InChI=1S/C22H25ClN6O2/c23-16-5-7-17(8-6-16)26-10-12-27(13-11-26)19(30)14-28-15-24-21-20(22(28)31)25-18-4-2-1-3-9-29(18)21/h5-8,15H,1-4,9-14H2

InChI Key

AYNVCOJLBXESMT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27601204

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.93

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.285

Distribution Coefficient, logD

2.284

Water Solubility, LogSw

-2.91

Polar Surface Area

58.781

Acid Dissociation Constant (pKa)

24.64

Base Dissociation Constant (pKb)

4.63

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.50

E714-0330 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Angiogenesis library (14822 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E714-0330 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E714-0330?
Check Price and Availability of E714-0330, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E714-0330 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E714-0330
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E714-0330
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E714-0330 available by request